Isildinha Reis

838 total citations
14 papers, 700 citations indexed

About

Isildinha Reis is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Isildinha Reis has authored 14 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Isildinha Reis's work include Retinoids in leukemia and cellular processes (3 papers), Acute Myeloid Leukemia Research (2 papers) and T-cell and Retrovirus Studies (2 papers). Isildinha Reis is often cited by papers focused on Retinoids in leukemia and cellular processes (3 papers), Acute Myeloid Leukemia Research (2 papers) and T-cell and Retrovirus Studies (2 papers). Isildinha Reis collaborates with scholars based in United States and United Kingdom. Isildinha Reis's co-authors include Nizar J. Bahlis, Lawrence Boise, William S. Dalton, Marc M. Oshiro, Jennifer M. Grad, Rakesh Singal, James J. Schlesselman, Kelvin P. Lee, Mark Goodman and Mohamed A. Kharfan‐Dabaja and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Isildinha Reis

12 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isildinha Reis United States	9	513	213	97	74	72	14	700
Kelly Davison Canada	9	639 1.2×	275 1.3×	50 0.5×	143 1.9×	28 0.4×	13	830
Mark W.C. Hatton Canada	15	363 0.7×	134 0.6×	38 0.4×	57 0.8×	107 1.5×	46	850
Chan H. Park United States	14	351 0.7×	74 0.3×	167 1.7×	170 2.3×	128 1.8×	22	783
Laura Porter United States	8	414 0.8×	119 0.6×	29 0.3×	179 2.4×	117 1.6×	12	689
T Repka United States	12	180 0.4×	312 1.5×	49 0.5×	363 4.9×	44 0.6×	18	974
Eugenia Prus Israel	16	364 0.7×	495 2.3×	139 1.4×	76 1.0×	64 0.9×	28	990
Daniel D. VonHoff United States	10	366 0.7×	52 0.2×	18 0.2×	205 2.8×	89 1.2×	13	654
C. Van Der Heul Netherlands	14	345 0.7×	198 0.9×	101 1.0×	42 0.6×	26 0.4×	29	698
Kensuke Naito Japan	18	660 1.3×	623 2.9×	19 0.2×	308 4.2×	32 0.4×	51	1.2k
Xuelan Zuo China	9	262 0.5×	60 0.3×	77 0.8×	82 1.1×	46 0.6×	25	516

Countries citing papers authored by Isildinha Reis

Since Specialization

Citations

This map shows the geographic impact of Isildinha Reis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isildinha Reis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isildinha Reis more than expected).

Fields of papers citing papers by Isildinha Reis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isildinha Reis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isildinha Reis. The network helps show where Isildinha Reis may publish in the future.

Co-authorship network of co-authors of Isildinha Reis

This figure shows the co-authorship network connecting the top 25 collaborators of Isildinha Reis. A scholar is included among the top collaborators of Isildinha Reis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isildinha Reis. Isildinha Reis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pongas, Georgios, Ngoc Toomey, Isildinha Reis, et al.. (2024). Safety and Efficacy of AZT-Interferon-α with Belinostat (AI-BEL) for HTLV-1 Related Adult T-Cell Leukemia-Lymphoma. Blood. 144(Supplement 1). 1720–1720.

Pollack, Alan, Elizabeth Bossart, Deukwoo Kwon, et al.. (2020). Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 107(2). 305–315. 28 indexed citations

Greer, Sheldon, et al.. (2016). Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic. Anti-Cancer Agents in Medicinal Chemistry. 17(2). 250–264. 4 indexed citations

Ernani, Vinicius, Jessica MacIntyre, Jaime R. Merchan, et al.. (2015). Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer.. Journal of Clinical Oncology. 33(3_suppl). 413–413. 2 indexed citations

Subbarayan, Pochi R., Malancha Sarkar, Pradeep Kumar, et al.. (2012). Achyranthes aspera (Apamarg) leaf extract inhibits human pancreatic tumor growth in athymic mice by apoptosis. Journal of Ethnopharmacology. 142(2). 523–530. 16 indexed citations

Reis, Isildinha, Michele Manrique, Lisa Cabral, et al.. (2012). The Combination of AZT/Interferon-α Therapy with the HDAC Inhibitor Valproic Acid for the Treatment of Adult T-Cell Leukemia/Lymphoma. Blood. 120(21). 4877–4877.

Zhao, Wei, et al.. (2011). Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas. Breast Cancer Research and Treatment. 131(3). 743–750. 59 indexed citations

Cook, Nicole, et al.. (2010). Role of patient race/ethnicity, insurance and age on Pap smear compliance across ten community health centers in Florida.. PubMed. 20(4). 321–6. 18 indexed citations

Landy, Howard J., Arnold M. Markoe, Niramol Savaraj, et al.. (2004). Pilot Study of Estramustine Added to Radiosurgery and Radiotherapy for Treatment of High Grade Glioma. Journal of Neuro-Oncology. 67(1-2). 215–220. 8 indexed citations

10.

Singal, Rakesh, et al.. (2004). Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. Oncology Reports. 12(3). 631–7. 62 indexed citations

11.

Singal, Rakesh, et al.. (2004). Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. International Journal of Oncology. 25(5). 1465–71. 46 indexed citations

12.

Bahlis, Nizar J., et al.. (2003). Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.. PubMed. 2(11). 1155–64. 59 indexed citations

13.

Bahlis, Nizar J., Isildinha Reis, Mohamed A. Kharfan‐Dabaja, et al.. (2002). Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma.. PubMed. 8(12). 3658–68. 164 indexed citations

14.

Grad, Jennifer M., Nizar J. Bahlis, Isildinha Reis, et al.. (2001). Ascorbic acid enhances arsenic trioxide–induced cytotoxicity in multiple myeloma cells. Blood. 98(3). 805–813. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact